These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6606219)

  • 61. Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection.
    Kauffmann RH; Van Es LA; Daha MR
    J Immunol Methods; 1979; 31(1-2):11-22. PubMed ID: 390054
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
    Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of a protein meal on three fluid-phase assays for circulating immune complexes.
    Elkon KB; Lanham JG; Dash AC; Hughes GR
    Clin Exp Immunol; 1981 Aug; 45(2):279-82. PubMed ID: 6976243
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of the soluble immune complexes that are detected by three different techniques.
    van der Giessen M; The TH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes.
    Collins MM; Casavant CH; Stites DP
    J Clin Microbiol; 1982 Mar; 15(3):456-64. PubMed ID: 6804486
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
    Wener MH; Mannik M
    Clin Exp Immunol; 1983 Jun; 52(3):543-50. PubMed ID: 6603296
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.
    Taylor RP; Andrews BS; Morley KW; Conlon T
    Rheumatol Int; 1981; 1(1):29-34. PubMed ID: 6981180
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
    Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
    J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence for the binding of human serum amyloid P component to Clq and Fab gamma.
    Bristow CL; Boackle RJ
    Mol Immunol; 1986 Oct; 23(10):1045-52. PubMed ID: 3099175
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The alternative complement pathway control protein H binds to immune complexes and serves their detection.
    Nydegger UE; Corvetta A; Spaeth PJ; Spycher M
    Clin Immunol Immunopathol; 1983 Jan; 26(1):56-65. PubMed ID: 6223741
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An enzymatically active antigen-antibody probe to measure circulating immune complexes. II. E. coli beta-galactosidase in the probe and C1q as the recognition unit.
    Migliorini P; Trovatello G; Cantarella S; Manca F; Bombardieri S; Celada F
    J Immunol Methods; 1983 Apr; 59(2):245-54. PubMed ID: 6404986
    [TBL] [Abstract][Full Text] [Related]  

  • 77. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay.
    Leatherbarrow RJ; Dwek RA
    Mol Immunol; 1984 Apr; 21(4):321-7. PubMed ID: 6610105
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An enzyme-linked immunoassay for circulating immune complexes using solid phased goat Clq.
    Lin TM; Halbert SP; Cort R; Blaschke MJ
    J Immunol Methods; 1983 Oct; 63(2):187-205. PubMed ID: 6194228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.